Alastair Proudfoot

Cardiac ICU @NHSBartsHealth. @The_MRC CARP programme supporting Cardiogenic shock research with @KnightGenetics & @QMUL. 🏏 and 🍷 often together..

[Circ: Heart Failure @CircHF]

Vasoactive treatment in cardiogenic shock varies widely across CICUs, driven by patient-level factors and institutional practice patterns @TIMIStudyGroup @DrRobRoswell @ICUDocAP @TIMIStudyGroup https://t.co/JiluwN0PIv

[Guy's & St Thomas' NHS Trust Critical Care @GSTT_ICU]

Fantastic leadership opportunity for a senior Intensive Care Medicine resident to become our first chief resident at @GSTT_ICU. New role that forms part of the Royal College of Physicians’ Chief Registrar leadership programme. Superb work by @DrWaqasAkhtar
https://t.co/35EK1drUCI

[Case Mix Programme @CMP_ICNARC]

All CMP units participating in the Cardiogenic Shock Module have now successfully transitioned to the new portal! 🚀

The new portal streamlines data collection, and marks a major milestone in the project.

Thanks to everyone who supported the rollout!

#CardiogenicShock #CMP

[Case Mix Programme @CMP_ICNARC]

🫀Interested in joining the Cardiogenic Shock Module?

With all units now live on the new CSM portal, it's the perfect time to get involved.

Help shape the future of cardiogenic shock care - email [email protected] to learn more!

#CardiogenicShock #CMP #ClinicalAudit

[Konstantin Krychtiuk @krychtiukmd]

Cardiogenic shock: diagnosis, phenotyping and management

- check out our international collaborative review in @yourICM led by Jacob Møller and @thiele_holger

@ICUDocAP #ECLS #ECMO #Impella #cardiogenicshock

https://t.co/kvD41pmbNq

[Heart_BMJ @Heart_BMJ]

Mechanical circulatory support for patients with infarct-related cardiogenic shock: a state-of-the-art review https://t.co/jpYpMl2ckl

[TIMI Study Group @TIMIStudyGroup]

New data from the @CCCTNetwork & @UmichCVC shows significant variation in vasoactive medication use in the treatment of cardiogenic shock across different CICU centers. 23% of variation was explained by local institutional practice alone. @davyhamilton1 @sidpatelMD #AHA24

[Alastair Proudfoot @ICUDocAP]

@iceman_ex Wisdom from @SVRaoMD as always. Hybrid approach for me: evidence based framework to guide decisions, listen to first responders with specific insights, consult the group where uncertainty but avoid groupthink and echo chambers. Missing link is the evidence…

[Alastair Proudfoot @ICUDocAP]

https://t.co/IaIVBmJIzm

[Alastair Proudfoot @ICUDocAP]

@VPanoulas @UddinAkhlaque Ok but given the patient selection, why is mortality 64% in 🇩🇰 in control arm (vs 50% in ECLS with 78% OHCA) and 15% greater than Germany/UK? Would best practices not translate to control as well or is the device the deal-breaker?

[Alastair Proudfoot @ICUDocAP]

@LukeAndreou @DrKeeble @phemDM @nandwics @drjasondungu @savodoc @Dizzledavies73 Your close neighbours @BartsHospital would be delighted to share their experiences

[Alastair Proudfoot @ICUDocAP]

@LukeAndreou @DrKeeble @phemDM @nandwics @drjasondungu @savodoc @Dizzledavies73 https://t.co/SR2EjPJq9X

[Charlotte Summers @charlot_summers]

Particularly great to hear about @ICNARC working with @ICUDocAP and colleagues to embed cardiogenic shock research in the Case Mix programme. Audit and research coming together to make care better for patients. @TheBHF @NIHRresearch

[Alex Warren @alexfwarren]

Really excited to share the results of the EPOCHS study, a collaborative multicentre observational study of cardiogenic shock in Scotland.

Highlights:
➡️ CS = 3% of ICU admissions in 🏴󠁧󠁢󠁳󠁣󠁴󠁿
➡️ Half due to acute MI, half other causes
➡️ 30-day mortality 54%

https://t.co/VPfD4MDKXP

[Alexandre Mebazaa @AlexMebazaa]

Many top European cardiogenic shock leaders had a great pasta dinner in Roma. @susannaprice @AntoineHerpain #DanielDeBacker #JacobMoller #robertorusso #alastairproudfoot #federicopappalardo @DavidGalliaerdt @JanBelohlavek

[Alastair Proudfoot @ICUDocAP]

Any medical trainees who have a clinical and research interest in the host response to OHCA out there? Have a proposal in progress with @KnightGenetics and @AntcliffeDavid in Oxford that would suit a fellowship application over next 6-12 months. DM me If interested.

[Emma Davenport @ee_davenport]

Sepsis is a highly heterogeneous condition resulting from the dysregulated host response to infection. Here we report our latest work with @KnightGenetics led by Katie Burnham. #sepsis #eqtl https://t.co/yXug6g7vEg

[Alastair Proudfoot @ICUDocAP]

@JasonKatzMD @BellevueHosp @nyulangone @glennfishman That’s the biggest transfer news since… Congrats @JasonKatzMD

[Alastair Proudfoot @ICUDocAP]

@ICS_updates @iceman_ex @mrbrownsauce @BartsHospital @FICMNews @bartspom @charlot_summers

[Alastair Proudfoot @ICUDocAP]

Last day ever of ICU for a man who many know as “GLI” or “greatest living intensivist”. Incredible clinician who influenced so many he has trained, immeasurably impacted ICU in the UK and saved so many lives through his wisdom and pursuit of excellence. Go well in retirement JC!